|
|
Volumn 15, Issue 6, 2004, Pages 503-505
|
|
Pharmaceutical biotechnology
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIGEN;
BACTERIAL VACCINE;
COAT PROTEIN;
DNA VACCINE;
HEPATITIS A VACCINE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
IMMUNOLOGICAL ADJUVANT;
IMMUNOPOTENTIATING RECONSTITUTED INFLUENZA VIROSOME;
INFLUENZA VACCINE;
LIPOSOME;
NUCLEIC ACID;
PROTEIN;
RECOMBINANT DNA;
RECOMBINANT VACCINE;
SMALLPOX VACCINE;
SUBUNIT VACCINE;
TOLL LIKE RECEPTOR 9 AGONIST;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR VACCINE;
UNCLASSIFIED DRUG;
VACCINIA VACCINE;
VIROSOME;
VIRUS HEMAGGLUTININ;
VIRUS PROTEIN;
VIRUS VECTOR;
ANTIMICROBIAL THERAPY;
BIOLOGICAL WARFARE;
BIOTECHNOLOGY;
COST EFFECTIVENESS ANALYSIS;
DRUG DELIVERY SYSTEM;
DRUG FORMULATION;
DRUG SAFETY;
EDITORIAL;
ENCAPSULATION;
EXPRESSION VECTOR;
HUMAN;
IMMUNE RESPONSE;
IMMUNITY;
IMMUNOGENICITY;
INFECTION;
INFECTION PREVENTION;
LIPID MEMBRANE;
MEMBRANE FUSION;
PRIORITY JOURNAL;
REPLICON;
SIDE EFFECT;
SMALLPOX;
VACCINATION;
VIRUS PARTICLE;
BACTERIA (MICROORGANISMS);
HUMAN IMMUNODEFICIENCY VIRUS;
VACCINIA;
VARIOLA VIRUS;
|
|
EID: 9244244151
PISSN: 09581669
EISSN: None
Source Type: Journal
DOI: 10.1016/S0958-1669(04)00147-8 Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|
